Described herein are antiviral compositions and apparatuses and methods of use thereof to inactivate a virus in contact with the composition or apparatus. The composition and/or apparatus include silicon nitride at a concentration of 1 weight percent to 15 weight percent and the silicon nitride inactivates at least 85 percent of the virus in contact with the composition and/or apparatus.

You do not currently have access to this content.